Association between chronological change of reproductive factors and breast cancer risk defined by hormone receptor status: results from the Seoul Breast Cancer Study

被引:26
|
作者
Chung, Seokang [1 ]
Park, Sue K. [1 ,2 ,3 ]
Sung, Hyuna [1 ]
Song, Nan [2 ]
Han, Wonshik [2 ,4 ]
Noh, Dong-Young [2 ,4 ]
Ahn, Sei-Hyun [5 ,6 ]
Yoo, Keun-Young [3 ]
Choi, Ji-Yeob [1 ,2 ]
Kang, Daehee [1 ,2 ,3 ]
机构
[1] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul 110799, South Korea
[2] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul 110799, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul 110799, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Surg, Seoul 110799, South Korea
[5] Univ Ulsan, Dept Surg, Coll Med, Seoul, South Korea
[6] ASAN Med Ctr, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
Breast cancer; Hormone receptor status; Chronological change; Reproductive factors; ESTROGEN-RECEPTOR; POSTMENOPAUSAL WOMEN; PHYSICAL-ACTIVITY; AGE; ETHNICITY; CARCINOMA; IMPACT; POLYMORPHISMS; PREVENTION; DIAGNOSIS;
D O I
10.1007/s10549-013-2645-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lifestyle factors have been chronologically changed into western style ones, which could result in the rapid increase of breast cancer incidence in Korea. It is plausible that reproductive factors through hormonal mechanisms are differentially related to the risk of breast cancer subtypes. We investigated the association of reproductive risk factors on breast cancer by birth year groups and also evaluated the differential associations on the hormone receptor-defined subtypes. Using the data from the Seoul Breast Cancer Study (SeBCS), a multicenter case-control study, 3,332 breast cancer patients and 3,620 control subjects were analyzed. The distribution of subtypes among cases was as follows: 61.0 % estrogen receptor (ER)-positive, 51.9 % progesterone receptor (PR)-positive, and 43.4 % both ER/PR-positive status, respectively. Polytomous logistic regression and Wald tests for heterogeneity have been used across the subtypes. The frequencies of reproductive-related risk factors including early age at menarche, nulligravid, age at first full-term pregnancy (FFTP), duration of estrogen exposure before FFTP (EEBF), less number of children, never breastfeeding, and short duration of breastfeeding has increased as women were born later in both cases and controls, respectively (p (trend) < 0.0001. Among breast cancer patients, either ER- or PR-positive subtypes were increased in women born in 1960s compared to women born in 1940s. Early age at menarche increased the risk of breast cancer regardless of the subtypes while nulligravid, late age at FFTP, and longer duration of EEBP were associated with hormone receptor-positive cancer risk only (p (heterogeneity) < 0.05), which associations were stronger among women born later. Our results suggest that the associations of age at menarche, parity, age at FFTP, and duration of EEBF with breast cancer risk were different based on the hormone receptor status and birth year groups in Korea.
引用
收藏
页码:557 / 565
页数:9
相关论文
共 50 条
  • [11] Breast cancer and ethnicity: Strong association between reproductive risk factors and estrogen receptor status in Asian patients - A retrospective study
    Menes, Tehillah S.
    Ozao, Junko
    Kim, Unsup
    BREAST JOURNAL, 2007, 13 (04) : 352 - 358
  • [12] Reproductive factors, tumor estrogen receptor status and contralateral breast cancer risk: results from the WECARE study
    Sisti, Julia S.
    Bernstein, Jonine L.
    Lynch, Charles F.
    Reiner, Anne S.
    Mellemkjaer, Lene
    Brooks, Jennifer D.
    Knight, Julia A.
    Bernstein, Leslie
    Malone, Kathleen E.
    Woods, Meghan
    Liang, Xiaolin
    John, Esther M.
    SPRINGERPLUS, 2015, 4 : 1 - 11
  • [13] Reproductive factors and hormone receptor status among very young (&lt;35 years) breast cancer patients
    Jia, Xiaoqing
    Liu, Guangyu
    Mo, Miao
    Cheng, Jingyi
    Shen, Zhenzhou
    Shao, Zhimin
    ONCOTARGET, 2015, 6 (27) : 24571 - 24580
  • [14] Association Between Contralateral Prophylactic Mastectomy and Breast Cancer Outcomes by Hormone Receptor Status
    Brewster, Abenaa M.
    Bedrosian, Isabelle
    Parker, Patricia A.
    Dong, Wenli
    Peterson, Susan K.
    Cantor, Scott B.
    Crosby, Melissa
    Shen, Yu
    CANCER, 2012, 118 (22) : 5637 - 5643
  • [15] Cumulative menstrual months and breast cancer risk by hormone receptor status and ethnicity: The Breast Cancer Etiology in Minorities Study
    Cole, Sarah E.
    John, Esther M.
    Hines, Lisa M.
    Phipps, Amanda, I
    Koo, Jocelyn
    Ingles, Sue A.
    Baumgartner, Kathy B.
    Slattery, Martha L.
    McKean-Cowden, Roberta
    Wu, Anna H.
    INTERNATIONAL JOURNAL OF CANCER, 2022, 150 (02) : 208 - 220
  • [16] Reproductive factors and breast cancer risk in relation to hormone receptor and menopausal status in Japanese women
    Kawai, Masaaki
    Kakugawa, Yoichiro
    Nishino, Yoshikazu
    Hamanaka, Yohei
    Ohuchi, Noriaki
    Minami, Yuko
    CANCER SCIENCE, 2012, 103 (10) : 1861 - 1870
  • [17] Reproductive factors, exogenous female hormone use and breast cancer risk in Japanese: the Miyagi Cohort Study
    Kawai, Masaaki
    Minami, Yuko
    Kuriyama, Shinichi
    Kakizaki, Masako
    Kakugawa, Yoichiro
    Nishino, Yoshikazu
    Ishida, Takanori
    Fukao, Akira
    Tsuji, Ichiro
    Ohuchi, Noriaki
    CANCER CAUSES & CONTROL, 2010, 21 (01) : 135 - 145
  • [18] Association between lifestyle, menstrual/reproductive history, and histological factors and risk of breast cancer in women biopsied for benign breast disease
    Arthur, Rhonda
    Wang, Yihong
    Ye, Kenny
    Glass, Andrew G.
    Ginsberg, Mindy
    Loudig, Olivier
    Rohan, Thomas
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 165 (03) : 623 - 631
  • [19] Reproductive factors and breast cancer risk in Palestine: A case control study
    El Sharif, Nuha
    Khatib, Imtithal
    CANCER EPIDEMIOLOGY, 2021, 74
  • [20] Effect of reproductive factors on stage, grade and hormone receptor status in early-onset breast cancer
    Joan A Largent
    Argyrios Ziogas
    Hoda Anton-Culver
    Breast Cancer Research, 7